Exact Mass: 219.1583

Exact Mass Matches: 219.1583

Found 72 metabolites which its exact mass value is equals to given mass value 219.1583, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Fabianine

C14H21NO (219.1623)

Allosedamine

(-)-Sedamine

C14H21NO (219.1623)

5-HTQ

N,N,N-Trimethylserotonin

C13H19N2O (219.1497)

Grotan

2-[3,5-bis(2-hydroxyethyl)-1,3,5-triazinan-1-yl]ethan-1-ol

C9H21N3O3 (219.1583)

3-(1-Propyl-3-piperidinyl)phenol

N-N-Propyl-3-(3-hydroxyphenyl)piperidine, S-(-)-isomer

C14H21NO (219.1623)

D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

(-)-7-Demethyl-desoxynupharidin|(9aS)-4t-furan-3-yl-1c-methyl-(9ar)-octahydro-quinolizine

C14H21NO (219.1623)

Hypusin

C9H21N3O3 (219.1583)

6-Ethoxy-2,3,4-trimethyl-1,2,3,4-tetrahydroquinoline

C14H21NO (219.1623)

CONFIDENCE standard compound; INTERNAL_ID 1319; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7195; ORIGINAL_PRECURSOR_SCAN_NO 7194 CONFIDENCE standard compound; INTERNAL_ID 1319; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7200; ORIGINAL_PRECURSOR_SCAN_NO 7199 CONFIDENCE standard compound; INTERNAL_ID 1319; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7217; ORIGINAL_PRECURSOR_SCAN_NO 7215 CONFIDENCE standard compound; INTERNAL_ID 1319; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7214; ORIGINAL_PRECURSOR_SCAN_NO 7212 CONFIDENCE standard compound; INTERNAL_ID 1319; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7230; ORIGINAL_PRECURSOR_SCAN_NO 7229 CONFIDENCE standard compound; INTERNAL_ID 1319; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7237; ORIGINAL_PRECURSOR_SCAN_NO 7236

2-cyclohexylamino-1-phenylethanol

C14H21NO (219.1623)

2-(1-BENZYL-PYRROLIDIN-3-YL)-PROPAN-2-OL

C14H21NO (219.1623)

(2-CYANO-PHENYL)-ACETICACIDETHYLESTER

C14H21NO (219.1623)

1-METHYL-4-(PIPERIDIN-4-YL)PIPERAZINE HYDROCHLORIDE

C10H22ClN3 (219.1502)

1-(1-Adamantyl)pyrrolidin-2-one

C14H21NO (219.1623)

1-(PYRIDIN-3-YL)NONAN-1-ONE

C14H21NO (219.1623)

1-(PYRIDIN-4-YL)NONAN-1-ONE

C14H21NO (219.1623)

N-BENZYL-4-(2-HYDROXYETHYL)PIPERIDINE

C14H21NO (219.1623)

3-(4-TERT-BUTOXY-PHENYL)-PYRROLIDINE

C14H21NO (219.1623)

CHEMBRDG-BB 4010741

C14H21NO (219.1623)

Benzamide,4-methyl-N,N-bis(1-methylethyl)-

C14H21NO (219.1623)

1-(PYRIDIN-2-YL)NONAN-1-ONE

C14H21NO (219.1623)

4-(3-phenylpropyl)piperidin-4-ol

C14H21NO (219.1623)

(S)-2-(1-Benzylpyrrolidin-2-yl)propan-2-ol

C14H21NO (219.1623)

N-(2-Phenoxyethyl)cyclohexanamine

C14H21NO (219.1623)

(S)-5-METHOXY-N-PROPYL-1,2,3,4-TETRAHYDRONAPHTHALEN-2-AMINE

C14H21NO (219.1623)

(-)-cis-2-benzylaminocyclohexanemethanol

C14H21NO (219.1623)

4-(AMINOMETHYL)-4-P-TOLYLCYCLOHEXANOL

C14H21NO (219.1623)

1H-Azepine,2-(2-ethoxyphenyl)hexahydro-(9CI)

C14H21NO (219.1623)

2-PROPYLAMINO-5-METHOXYTETRALIN

C14H21NO (219.1623)

2-(1-benzylpyrrolidin-2-yl)propan-2-ol

C14H21NO (219.1623)

2-(4-methoxyphenyl)-5-methylazepane

C14H21NO (219.1623)

2-PHENYL-3-PIPERIDIN-1-YL-PROPAN-1-OL

C14H21NO (219.1623)

N-{3-[Dimethoxy(methyl)silyl]propyl}-1-butanamine

C10H25NO2Si (219.1654)

Zylofuramine

C14H21NO (219.1623)

4-[(4-ethoxyphenyl)methyl]piperidine

C14H21NO (219.1623)

4-[[di(propan-2-yl)amino]methyl]benzaldehyde

C14H21NO (219.1623)

[(1R,2S)-2-(Benzylamino)cyclohexyl]methanol

C14H21NO (219.1623)

N-cyclohexyl-4-ethoxyaniline

C14H21NO (219.1623)

3-(2-propan-2-ylphenoxy)piperidine

C14H21NO (219.1623)

4-PIPERIDINOL, 3,3-DIMETHYL-1-(PHENYLMETHYL)-

C14H21NO (219.1623)

CHEMBRDG-BB 4010734

C14H21NO (219.1623)

2-[(3-ethoxyphenyl)methyl]piperidine

C14H21NO (219.1623)

4-Aminooctanophenone

C14H21NO (219.1623)

Quinoline, 4-ethoxy-1,2,3,4-tetrahydro-2,6,7-trimethyl- (9CI)

C14H21NO (219.1623)

3-[(4-ethoxyphenyl)methyl]piperidine

C14H21NO (219.1623)

3-Butyl-1,2-dimethyl-1H-imidazol-3-ium dicyanoazanide

C11H17N5 (219.1484)

1H-Azepine-3-Methanol, hexahydro-1-(phenylMethyl)-

C14H21NO (219.1623)

3-(4-Phenyl-1-piperidinyl)-1-propanol

C14H21NO (219.1623)

n-alpha-acetyl-l-lysine-n-methylamide monohydrate

C9H21N3O3 (219.1583)

1H-Azepine,2-(4-ethoxyphenyl)hexahydro-(9CI)

C14H21NO (219.1623)

2-(3-Ethoxyphenyl)azepane

C14H21NO (219.1623)

2-(3,4-DIMETHYL-PHENYL)-AZEPANE

C14H21NO (219.1623)

6-n-hexylaminopurine

C11H17N5 (219.1484)

N-[(4-ethylphenyl)methyl]-1-(oxolan-2-yl)methanamine

C14H21NO (219.1623)

1-(4-CHLORO-2-NITROPHENYL)-3-METHYLPIPERAZINE HYDROCHLORIDE

C14H21NO (219.1623)

Hexen

C14H21NO (219.1623)

Cinobufotenine

C13H19N2O+ (219.1497)

D009676 - Noxae > D011042 - Poisons > D014688 - Venoms

4-(2-Aminoethyl)-2-cyclohexylphenol

C14H21NO (219.1623)

497-88-1

(1S)-2-[(2S)-1-methylpiperidin-2-yl]-1-phenyl-ethanol

C14H21NO (219.1623)

4-hydroxy-N,N,N-trimethyltryptamine

C13H19N2O+ (219.1497)

(-)-Sedamine

C14H21NO (219.1623)

3-(1-Propyl-3-piperidinyl)phenol

C14H21NO (219.1623)

D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

5-HTQ

N,N,N-Trimethylserotonin

C13H19N2O+ (219.1497)

D009676 - Noxae > D011042 - Poisons > D014688 - Venoms

(R)-Preclamol

C14H21NO (219.1623)

(R)-Preclamol is a dopamine (DA) agonist with autoreceptor as well as postsynaptic receptor stimulatory properties. (R)-Preclamol inhibits the locomotor activity of mice and rats in low doses[1].

(2s,2's)-sedamine

C14H21NO (219.1623)

{"Ingredient_id": "HBIN006613","Ingredient_name": "(2s,2's)-sedamine","Alias": "NA","Ingredient_formula": "C14H21NO","Ingredient_Smile": "CN1CCCCC1CC(C2=CC=CC=C2)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "19632","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}